Related Experiment Video
Updated: Aug 20, 2026
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Emerging technologies for the identification of therapeutic targets for the management of pre-eclampsia
Insights
Pre-eclampsia, a pregnancy complication causing hypertension, may soon be diagnosed early. Research is identifying specific placental indicators for timely intervention and new treatments.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Reproductive Biology
Background:
- Pre-eclampsia is a significant pregnancy complication defined by hypertension and proteinuria.
- Both genetic and environmental factors contribute to pre-eclampsia development and progression.
Discussion:
- Advances in experimental systems and analytical methods are crucial for studying placental differences.
- These methods are nearing the identification of specific disease indicators.
Key Insights:
- Early diagnosis of pre-eclampsia is becoming more attainable.
- Identifying specific indicators allows for prompt intervention.
- This research may reveal therapeutic targets for pre-eclampsia.
Outlook:
- Future research will focus on validating identified indicators.
- Development of novel therapeutic agents against pre-eclampsia is a key goal.
- Improved patient outcomes through early detection and treatment are anticipated.
Abstract:
Pre-eclampsia is a common and serious complication of pregnancy characterised by hypertension and proteinuria. Genetic and environmental factors influence the occurrence and progression of the disease. Emerging experimental systems and increasingly specific analytical methods for the study of differences between normal and pre-eclamptic placentae are close to identifying specific indicators of disease, which may allow early diagnosis and intervention and reveal targets against which therapeutic agents can be developed.
